[ Monteris Medical raises $26.6M in Series C ]

Monteris Medical has raised $26.6 million in Series C funding.

Founded in 1999, Monteris Medical designs, manufactures and markets MRI-guided laser ablation systems for the treatment of brain lesions. Monteris  markets the NeuroBlate® System in the United States and Canada as a surgical tool that provides neurosurgeons an alternative to traditional craniotomies.

The company will use the funds raised to invest in further innovation, clinical research and commercial expansion.

Funding  Series C
Founded  1999
Country  USA
City  Plymouth, Minnesota
Founder / CEO  Marty Emerson
Deal Size  $26.6M
Investors  BDC Venture Capital
 SightLine Partners
 Birchview Fund
 Versant Ventures
Previous Investors  Business Development Bank of  Canada
 Oxford Finance Corporation
 The Vertical Group
 BDC Venture Capital
 SWMF Life Science Fund